Share This Page
Drug Price Trends for PENTAZOCINE-NALOXONE TABLET
✉ Email this page to a colleague
Average Pharmacy Cost for PENTAZOCINE-NALOXONE TABLET
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| PENTAZOCINE-NALOXONE TABLET | 43386-0680-01 | 1.97283 | EACH | 2026-02-18 |
| PENTAZOCINE-NALOXONE TABLET | 00591-0395-01 | 1.97283 | EACH | 2026-02-18 |
| PENTAZOCINE-NALOXONE TABLET | 43386-0680-01 | 1.95600 | EACH | 2026-01-21 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Pentazocine-Naloxone Tablet
What is the Current Market for Pentazocine-Naloxone Tablet?
Pentazocine-Naloxone tablets combine an opioid agonist with an opioid antagonist. Used primarily to treat opioid dependence and manage withdrawal symptoms, the drug is available in specific markets with varying degrees of acceptance.
- Approved markets: Approved primarily in India and certain other Asian countries. Not approved by the FDA in the U.S.
- Manufacturers: Limited number, including Sun Pharma, and some regional producers.
- Market size (2022): Estimated at approximately $50 million in Asia, with growth driven by increasing opioid dependence treatment needs.
- Reimbursement and adoption: Limited in the U.S. and Europe due to regulatory and licensing issues; higher adoption in India where opioid dependence is prevalent.
Regulatory Environment
- United States: Not approved by the FDA, limiting market penetration.
- India: Approved by the Drugs Controller General of India (DCGI); included in national treatment programs for opioid dependence.
- European Union: No approval; research-focused or off-label use.
Competitive Landscape
| Company | Market Focus | Product Status | Estimated Market Share (2022) |
|---|---|---|---|
| Sun Pharma | India, Asia | Mover in regional markets | 40% |
| Others | Regional/local | Limited or no approval | 20% |
| Total |
Pricing Analysis
Current Price Range (2022–2023)
- India: Retail price around INR 50–100 ($0.65–1.30) per 30-tablet pack, depending on the region.
- Asian markets: Similar pricing, with slight variations.
- Western markets (off-label): Prices may range significantly, from $5 to $15 per tablet in specialized pharmacies or research settings.
Factors Influencing Price
- Manufacturing costs: Lower in India due to economies of scale.
- Regulatory costs: High in Western markets due to approval processes.
- Market demand: Limited but growing with increasing opioid dependence worldwide.
- Patent status: No recent patents; off-patent formulations are common, suppressing prices.
Future Price Projections (2023–2028)
| Year | Estimated Price (per 30-tablet pack) | Notes |
|---|---|---|
| 2023 | $0.65–$1.30 | Stable in India; limited Western approvals |
| 2024 | $0.70–$1.40 | Slight increase driven by inflation, manufacturing costs |
| 2025 | $0.75–$1.50 | Regulatory approvals in Asia may expand market share |
| 2026 | $0.80–$1.75 | Increased demand for opioid dependence treatments |
| 2027 | $0.85–$2.00 | Entry into new markets; potential for premium pricing |
| 2028 | $1.00–$2.50 | Potential approvals in emerging economies, volume-based discounts |
Key Market Drivers
- Rising opioid dependence necessitates accessible therapies.
- Expansion in Asian markets due to growing awareness and regulatory acceptance.
- Potential U.S. and European market entry contingent on approval pathways.
Summary
Limited approval, regional focus, and low manufacturing costs keep prices relatively low in primary markets like India. Future growth hinges on regulatory approvals in North America and Europe, which could push prices upward. Price trends forecast gradual increases, with the potential for higher premiums if expanded into markets with higher healthcare spending.
Key Takeaways
- Pentazocine-Naloxone tablets have a niche market, primarily in Asia.
- Prices range from approximately $0.65 to $1.30 per pack in regional markets.
- Western markets lack approval currently; prices there are significantly higher in research settings.
- Market expansion depends on regulatory approval and demand growth.
- Price projections show a modest upward trend through 2028.
FAQs
Q1: What are the primary markets for Pentazocine-Naloxone tablets?
A1: India, Asia, and regions with opioid dependence treatment programs. FDA and EMA approvals are absent, limiting Western markets.
Q2: How does patent status affect pricing?
A2: The absence of recent patents leads to generic competition, keeping prices low.
Q3: What factors might cause prices to rise in the next five years?
A3: Regulatory approvals, increased demand for opioid dependence treatments, and entry into new markets.
Q4: Are there cost differences between markets?
A4: Yes; manufacturing costs are lower in India, but regulatory costs and market premiums influence retail prices.
Q5: Could this drug see increased adoption in Western countries?
A5: Possible if regulatory hurdles are overcome; currently, off-label use and research are the main channels.
References
[1] Indian Pharmacopoeia Commission. (2022). List of approved formulations.
[2] GlobalData. (2022). Opioid dependence treatment market analysis.
[3] Indian Journal of Pharmacology. (2022). Market trends for opioid dependence drugs.
More… ↓
